Award
National Cancer Institute 5R01CA276279-04
The Role of Egfl6 in Tumor Immunity
Recipient
Magee-Women's Research Institute and Foundation
Award Amount
$311,352.00
Ceiling
$311,352.00
Awarded
May 27, 2026
Identifier
5R01CA276279-04
Research grant awarded to study the role of Egfl6 in tumor immunity, focusing on ovarian cancer and improving immunotherapy outcomes through therapeutic antibodies.
Description
This grant supports research on the immunoregulatory role of Egfl6 in ovarian tumor microenvironment and aims to develop therapeutic antibodies to improve immunotherapy outcomes.